AAPL vs ISRG: Which Is the Better Buy?
Side-by-side comparison of Apple Inc. and Intuitive Surgical, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-25.
Apple Inc. · Technology
$337.02
+9.9% upside to fair value
Med Conviction
Grade B
High Quality
VS
Intuitive Surgical, Inc. · Healthcare
$399.52
+22.4% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
ISRG has more upside to fair value
(+22.4%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
AAPL |
ISRG |
| Current Price |
$337.02 |
$399.52 |
| Fair Value Estimate |
$370.54 |
$488.97 |
| Upside to Fair Value |
+9.9%
|
+22.4%
|
| Market Cap |
$4,949.9B |
$141.1B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
29.6x
|
30.7x
|
| Price / Sales |
10.6x
|
12.8x
|
| Price / FCF |
36.2x
|
44.0x
|
| Revenue Growth YoY |
+16.4%
|
+18.5%
|
| Gross Margin |
48.7%
|
66.7%
|
| Operating Margin |
33.2%
|
31.3%
|
| Return on Equity |
137.2%
|
17.8%
|
| Dividend Yield |
0.31% |
0% |
| FCF Yield |
2.76%
|
2.28%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
Apple Inc. is a global consumer-electronics and services platform whose hardware lineup (iPhone, Mac, iPad, wearables) and digital ecosystem (App Store, Apple Music, iCloud, Apple Pay, advertising) generated $31.78 of revenue per share and $9.30 of free cash flow per share on a trailing basis, with TTM gross margin of 48.7%, operating margin of 33.2%, net margin of 27.6%, and ROE of 137.2%. Busin…
Intuitive Surgical develops, produces, and commercializes the da Vinci surgical system and the Ion endoluminal system, along with instruments, accessories, training, and digital solutions that drive a large installed-base and recurring-revenue model. Business quality is high: TTM gross margin of 66.7%, operating margin of 31.3%, net margin of 28.4%, ROE of 17.8%, and revenue growth of 18.5% with …
Accumulation Zones
| Metric |
AAPL |
ISRG |
| Zone Low |
$277.91 |
$366.73 |
| Zone High |
$314.96 |
$415.62 |
| In Buy Zone? |
No
|
Yes
|